Off-label marketing (or promotion) type of qui tam lawsuits, brought by whistleblowers against pharmaceutical companies, have yielded some of the largest recoveries for the government and the whistleblowers. Every drug or medical device sold in the USA must be approved by the FDA. Off-label marketing is a practice by pharmaceutical and medical device companies to market its products for use that is not approved by the FDA.

Whistleblowers who report off-label marketing may receive a share in the government's recovery.

If you have any first-hand knowledge, information or evidence related to off-label marketing or promotion, please contact the national qui tam law firm of Levy Phillips & Konigsberg LLP ([ Ссылка ]) for a free and confidential consultation. Please call their toll-free 24/7 hotline at 1-888-372-8387 or 1-212-605-6200.

Disclaimer: www.lpklaw.com/video-disclaimer.php

свернуть